TCL Archive Advisors Discuss NCI Intramural Program In Closed Session, Defend Process December 16, 1994
TCL Archive New Phase III Follow-Up Data of Yervoy Trial Shows 19 Percent Survival at Four Years October 26, 2012
TCL Archive ASCO Must Be An “Independent Voice” For Cancer Patients and Physicians, New EVP Allen Lichter says. July 28, 2006
TCL Archive Defying critics, von Eschenbach describes hands-on role at NCI while running FDA. NCI is unified behind 2015 goal, he says. December 9, 2005
